BIOMAT Database Logo BIOMAT Database Logo

[Shock therapy with vasodilator and-or vasoconstrictor agents]. 1967

G Wolff, and J P Gigon, and F Enderlin

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D012769 Shock A pathological condition manifested by failure to perfuse or oxygenate vital organs. Circulatory Collapse,Circulatory Failure,Hypovolemic Shock,Collapse, Circulatory,Failure, Circulatory,Shock, Hypovolemic

Related Publications

G Wolff, and J P Gigon, and F Enderlin
In vitro femoral arterial responses to vasoconstrictor and vasodilator agents in endotoxin shock.
January 1994, Life sciences,
G Wolff, and J P Gigon, and F Enderlin
[Editorial: Vasodilator agents and shock].
September 1973, Boletin de la Asociacion Medica de Puerto Rico,
G Wolff, and J P Gigon, and F Enderlin
[Use of vasoconstrictor agents in shock].
September 1967, Gaceta medica de Mexico,
G Wolff, and J P Gigon, and F Enderlin
Carbon monoxide: vasoconstrictor or vasodilator? That's the question.
October 2008, American journal of physiology. Renal physiology,
G Wolff, and J P Gigon, and F Enderlin
[Are vasodilator or vasoconstrictor medications necessary for the prevention and therapy of posttraumatic edema?].
April 1960, Munchener medizinische Wochenschrift (1950),
G Wolff, and J P Gigon, and F Enderlin
Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep.
April 1988, Anesthesiology,
G Wolff, and J P Gigon, and F Enderlin
[Effect of vasodilator and vasoconstrictor agents on the resistance of arteries and arterioles].
January 1969, Farmakologiia i toksikologiia,
G Wolff, and J P Gigon, and F Enderlin
[Therapy of heart failure with vasodilator agents].
January 1988, Zeitschrift fur Kardiologie,
G Wolff, and J P Gigon, and F Enderlin
Vasoconstrictor and vasodilator effects of hypoxia.
February 1994, Trends in pharmacological sciences,
G Wolff, and J P Gigon, and F Enderlin
Modes of vasoconstrictor and vasodilator neurotransmission.
January 1978, Blood vessels,
Copied contents to your clipboard!